MedPath

Examination of the usefulness of kangen-karyu in the metabolic syndrome patient

Not Applicable
Completed
Conditions
metabolic syndrome
Registration Number
JPRN-UMIN000032765
Lead Sponsor
shinseikai toyama hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
5
Inclusion Criteria

Not provided

Exclusion Criteria

The patient who judged that a doctor was inappropriate

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
We evaluate home blood pressure, degree of obesity , total cholesterol, LDL cholesterol, HDL cholesterol, triglyceride , HbA1C, after taking kangen-karyu for six months
Secondary Outcome Measures
NameTimeMethod
We evaluate subjective symptoms "kitai", "oketu" after taking kangen-karyu for six months
© Copyright 2025. All Rights Reserved by MedPath